My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 159

    1.

    Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques.

    Koegler FH, Enriori PJ, Billes SK, Takahashi DL, Martin MS, Clark RL, Evans AE, Grove KL, Cameron JL, Cowley MA.

    Diabetes. 2005 Nov;54(11):3198-204.PMID: 16249445 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats.

    Chelikani PK, Haver AC, Reeve JR Jr, Keire DA, Reidelberger RD.

    Am J Physiol Regul Integr Comp Physiol. 2006 Feb;290(2):R298-305. Epub 2005 Oct 6.PMID: 16210414 [PubMed - indexed for MEDLINE]Related articles

    3.

    Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys.

    Moran TH, Smedh U, Kinzig KP, Scott KA, Knipp S, Ladenheim EE.

    Am J Physiol Regul Integr Comp Physiol. 2005 Feb;288(2):R384-8. Epub 2004 Sep 23.PMID: 15388494 [PubMed - indexed for MEDLINE]Related articles

    4.

    Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.

    Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG.

    Endocrinology. 2007 Dec;148(12):6054-61. Epub 2007 Aug 30.PMID: 17761760 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats.

    Reidelberger RD, Haver AC, Chelikani PK, Buescher JL.

    Am J Physiol Regul Integr Comp Physiol. 2008 Aug;295(2):R449-58. Epub 2008 Jun 11.PMID: 18550871 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Am J Physiol Regul Integr Comp Physiol. 2007 Jul;293(1):R39-46. Epub 2007 Apr 11.PMID: 17428898 [PubMed - indexed for MEDLINE]Related articles

    7.

    Gut hormone PYY(3-36) physiologically inhibits food intake.

    Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR.

    Nature. 2002 Aug 8;418(6898):650-4.PMID: 12167864 [PubMed - indexed for MEDLINE]Related articles

    8.

    Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.

    Neary NM, Small CJ, Druce MR, Park AJ, Ellis SM, Semjonous NM, Dakin CL, Filipsson K, Wang F, Kent AS, Frost GS, Ghatei MA, Bloom SR.

    Endocrinology. 2005 Dec;146(12):5120-7. Epub 2005 Sep 8.PMID: 16150917 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity.

    Vrang N, Madsen AN, Tang-Christensen M, Hansen G, Larsen PJ.

    Am J Physiol Regul Integr Comp Physiol. 2006 Aug;291(2):R367-75. Epub 2006 Apr 13.PMID: 16914421 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of PYY[3-36] in rodent models of diabetes and obesity.

    Pittner RA, Moore CX, Bhavsar SP, Gedulin BR, Smith PA, Jodka CM, Parkes DG, Paterniti JR, Srivastava VP, Young AA.

    Int J Obes Relat Metab Disord. 2004 Aug;28(8):963-71.PMID: 15197409 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of the metabolic effects of GIP receptor antagonism and PYY(3-36) receptor activation in high fat fed mice.

    Irwin N, Hunter K, Flatt PR.

    Peptides. 2007 Nov;28(11):2192-8. Epub 2007 Aug 19.PMID: 17884253 [PubMed - indexed for MEDLINE]Related articles

    12.

    Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Endocrinology. 2005 Feb;146(2):879-88. Epub 2004 Nov 11.PMID: 15539554 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The gut hormone peptide YY regulates appetite.

    Batterham RL, Bloom SR.

    Ann N Y Acad Sci. 2003 Jun;994:162-8.PMID: 12851312 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of total colectomy and PYY infusion on food intake and body weight in rats.

    Babu M, Purhonen AK, Bansiewicz T, Mäkelä K, Walkowiak J, Miettinen P, Herzig KH.

    Regul Pept. 2005 Nov;131(1-3):29-33.PMID: 15996768 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats.

    Chelikani PK, Haver AC, Reidelberger RD.

    Diabetes. 2006 Nov;55(11):3038-46.PMID: 17065340 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    PYY transgenic mice are protected against diet-induced and genetic obesity.

    Boey D, Lin S, Enriquez RF, Lee NJ, Slack K, Couzens M, Baldock PA, Herzog H, Sainsbury A.

    Neuropeptides. 2008 Feb;42(1):19-30. Epub 2007 Dec 27.PMID: 18164057 [PubMed - indexed for MEDLINE]Related articles

    17.

    PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.

    Adams SH, Lei C, Jodka CM, Nikoulina SE, Hoyt JA, Gedulin B, Mack CM, Kendall ES.

    J Nutr. 2006 Jan;136(1):195-201.PMID: 16365082 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Leptin extends the anorectic effects of chronic PYY(3-36) administration in ad libitum-fed rats.

    Unniappan S, Kieffer TJ.

    Am J Physiol Regul Integr Comp Physiol. 2008 Jul;295(1):R51-8. Epub 2008 Apr 16.PMID: 18417649 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity.

    Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, Couzens M, Slack K, Dallmann R, Sainsbury A, Herzog H.

    Diabetologia. 2006 Jun;49(6):1360-70. Epub 2006 Apr 21.PMID: 16680491 [PubMed - indexed for MEDLINE]Related articles

    20.

    Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake.

    Abbott CR, Small CJ, Kennedy AR, Neary NM, Sajedi A, Ghatei MA, Bloom SR.

    Brain Res. 2005 May 10;1043(1-2):139-44.PMID: 15862527 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity